Partner Field Studies RALEIGH, N.C., Feb. 2 /PRNewswire/ -- The Contemporary Science Center (CSC) is pleased to announce the launch of its first programs, with sponsorship from Progress Energy, MCNC and Inspire Pharmaceuticals. The CSC is introducing two programs this year. The Curriculum Partners Field Studies program, sponsored by Progress Energy and Inspire Pharmaceuticals, will enable teachers across North Carolina to bring their science students for a daylong field study to RTP. Students will get to spend a day experiencing authentic science and doing real experiments from RTP companies. These studies, eighteen months in development, put teenagers in the roles of scientists faced with real problems from Inspire and Constella, from figuring out the right dosage of a new compound for Cystic Fibrosis to developing better practices for paramedics to prevent blood exposure. "Our goal at the Contemporary Science Center is to change teenagers' experience of science -- and, by that, to entice more students across North Carolina to continue studying science and math, and to consider careers in science," said Pamela Blizzard, executive director of the CSC. Progress Energy and Inspire are pleased to sponsor this program and its efforts to bring the best of RTP to high school students across the state. "The field study program will enable students to get excited about math and science through hands-on experiments," said Tammy Brown, manager of community relations for Progress Energy. "We are pleased to be one of the original sponsors of what we expect will be a successful program for the Contemporary Science Center and a rewarding experience for students." The Entrepreneurs in Science (EIS) Summer Camp, sponsored by MCNC, will combine science explorations from Inspire Pharmaceuticals and The Constella Group with the Council for Entrepreneurial Development's entrepreneurism curriculum. The EIS summer camp for teenagers will be a week long immersion in the science and start-ups that make Research Triangle Park unique. "These activities align well with MCNC's mission to promote technology-led economic development and job creation in North Carolina," said David Rizzo, chief executive officer and president of MCNC. "The summer camp and the Contemporary Science Center will inspire future entrepreneurs and scientists." The Contemporary Science Center is a science education venture that enables teenagers across North Carolina to experience cutting-edge discoveries from Research Triangle Park companies. The CSC works with RTP companies to re-create their key scientific discoveries into daylong experiences that high school students can interact with. These studies will be led by CSC staff teachers at sites in the Triangle area. The Contemporary Science Center currently has two studies linked with high school biology and math, and is in conversation with new RTP companies for new field studies. Visit www.contemporarysciencecenter.org for more information. About MCNC MCNC is a private, independent, non-profit corporation established in 1980 to advance technology-led economic development and job creation throughout North Carolina. MCNC Research & Development Institute develops new technologies through its own initiatives and as a research partner for the U.S. government, conducting advanced and applied research across a broad technology spectrum, including microsystems, flexible electronics, sensor development, signal electronics, wireless systems, microfabrication, high-speed secure networks and grid computing. MCNC Grid Computing & Networking Services delivers advanced communications resources statewide to more than 180 public and private institutions, including universities, community colleges, K-12 schools, libraries, state government, private research institutions and commercial businesses. MCNC Ventures provides early-stage funding and assistance to entrepreneurial start-up companies. The MCNC family of companies is located in North Carolina's Research Triangle Park. For more information, please visit www.mcnc.org . Progress Energy (formerly CP&L) (NYSE: PGN), is headquartered in Raleigh and is a Fortune 250 diversified energy company with more than 23,000 megawatts of generation capacity and $8 billion in annual revenues. The company's holdings include two electric utilities serving more than 2.8 million customers in North Carolina, South Carolina and Florida. Progress Energy also includes non-regulated operations covering merchant generation, energy marketing, natural gas exploration, fuel extraction, rail services and broadband capacity. The Progress Energy Foundation was formed in November 2000, following the merger of CP&L and the Florida Progress Corporation. Although the name is new, Progress Energy has a long-standing relationship with the communities it serves through its utility companies. The foundation partners with non-profits in Florida, North Carolina and South Carolina to improve customers' lives. Grants focus on education, the environment and economic development. During 2003, the foundation invested almost $9 million in the communities it serves. Inspire Pharmaceuticals, Inc. discovers and develops new drugs to treat diseases characterized by deficiencies in the body's innate defense mechanisms of mucosal hydration and mucociliary clearance, as well as other non-mucosal disorders. These mechanisms are the natural way that the body defends its mucosal surfaces against dust, pollutants, bacteria and viruses. Mucosal hydration involves the moistening of the body's mucosal surfaces, and mucociliary clearance involves a blanket-like movement of fluid and particles from the lungs and sinuses. Mucosal surfaces are tissues containing specialized cells that lubricate and protect surfaces of organs that are directly exposed to the outside environment, such as the lungs, eyes and sinuses. Our lead products target respiratory and ophthalmic diseases with inadequate current treatments and which represent large market opportunities. We have advanced one product to an NDA and have four additional product candidates in clinical development. We have development and commercialization alliances with Allergan, Inc., Santen Pharmaceutical Co., Ltd., and Kirin Brewery Co., Ltd. Our products are based on our proprietary technology relating to P2Y receptors. We are exploring other target diseases where we believe P2Y receptors play important biological roles. SOURCE Contemporary Science Center -0- 02/02/2004 /NOTE TO EDITORS: Photos available on request./ /CONTACT: Mary Bennett, Sr. VP, Operations and Director of Communications of Inspire Pharmaceuticals, +1-919-287-1245, or firstname.lastname@example.org; Scott Yates, Director of Communications of MCNC, +1-919-248-1907, or email@example.com; Merrilee Jacobson, Contributions Specialist of Progress Energy, +1-919-546-6441, or firstname.lastname@example.org; or Pamela Blizzard, Executive Director of the Contemporary Science Center, +1-919-426-4274, or Pamela@contemporarysciencecenter.org/ /Web site: http://www.contemporarysciencecenter.org http://www.mcnc.org http://www.progress-energy.com / (PGN) CO: Contemporary Science Center; Progress Energy, Inc.; MCNC Research & Development Institute; Inspire Pharmaceuticals, Inc. ST: North Carolina IN: UTI HEA EDU SU: CHI NPT -0- Feb/02/2004 15:23 GMT
Contemporary Science Center Launches Summer Camp and Curriculum
Press spacebar to pause and continue. Press esc to stop.